Dystrobrevin Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Dystrobrevin monoclonal antibodies for investigating dystrobrevin's role in cellular processes. Dystrobrevin monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Dystrobrevin is a crucial component of the dystrophin-associated protein complex, playing a significant role in maintaining the structural integrity of muscle cells and facilitating communication between the cytoskeleton and the extracellular matrix. Research has shown that dystrobrevin significantly influences muscle function, and its study is particularly relevant to understanding muscular dystrophies. Investigating dystrobrevin's molecular mechanisms can reveal potential therapeutic targets for muscle-related disorders. Researchers worldwide utilize dystrobrevin monoclonal antibodies to advance their understanding of muscle biology and disease progression. Current studies focusing on dystrobrevin continue to uncover new aspects of muscle cell regulation and maintenance. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in advancing muscle biology research and developing potential treatments for muscular disorders.